Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Myopia (COAST_UAmCNV)
Collaborative Ocular Antiangiogenic Study of Ukraine. Multicentral, Open-label, Randomized, Prospective Study of Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Myopia
Sponsor: Central Polyclinic of Internal Affairs of Ukraine
Listed as NCT03963596, this NA trial focuses on Pathologic Myopia and remains completed. Sponsored by Central Polyclinic of Internal Affairs of Ukraine, it has been updated 8 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Feb 2023 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
May 2022 — Feb 2023 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Jan 2021 — May 2022 [monthly]
Recruiting NA
-
May 2020 — Jan 2021 [monthly]
Recruiting NA
-
Jun 2019 — May 2020 [monthly]
Recruiting NA
First recorded
Mar 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Central Polyclinic of Internal Affairs of Ukraine
- Mykolaiv Region Ophthalmogical Hospital
- Odessa National Medical University
- The Filatov Institute of Eye Diseases and Tissue Therapy
For direct contact, visit the study record on ClinicalTrials.gov .